UnitedHealth Group (UNH) Q4 2024 earnings summary

Executive summary

• 2024 revenues reached $400.3 billion, up 8% year-over-year, with adjusted EPS of $27.66, both within prior outlook ranges.

• Navigated significant challenges including Medicare rate cuts, Medicaid redeterminations, a major cyberattack, and South America exit, yet delivered on commitments.

• Strategic focus on value-based care, digital transformation, and consumer experience improvements.

• Ongoing portfolio optimization, including de-emphasizing urgent care and legacy contracts, to enhance future growth.

• Cash flows from operations totaled $24.2 billion, or 1.6x net income, supporting robust capital returns.

Financial highlights

• Full year operating earnings were $32.3 billion; adjusted operating earnings (excluding cyberattack and South America impacts) were $34.4 billion.

• Operating cost ratio improved by 150 basis points year-over-year, reaching 13.2% from 14.7% in 2023.

• Nearly $17 billion deployed in growth capital and over $16 billion returned to shareholders in 2024.

• Optum Health revenues reached $105 billion in 2024, expected to approach $117 billion in 2025.

• Optum Rx revenues grew to over $130 billion in 2024, with 2025 guidance at $146 billion.

Outlook and guidance

• 2025 guidance: revenues of $450–$455 billion, adjusted net earnings of $29.50–$30.00 per share, and operating cash flow of $32–$33 billion.

• 2025 full-year medical care ratio (MCR) expected at 86.5% ± 50 bps, 100 bps above 2024.

• Confident in 2025 pricing adequacy, with care activity assumptions aligned to 2024 trends.

• Long-term growth objective reaffirmed at 13%-16% per year.

• Growth expected from expanded value-based care and new state contracts.